Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Obesity 3Urologic Neoplasms 1Stomach Neoplasms 1Smoking 1Sarcopenia 1Risk Reduction Behavior 1Rectal Neoplasms 1Postoperative Complications 1Patient Preference 1Overweight 1Motor Activity 1Malnutrition 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Alcohol Drinking 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 75Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Adiposity × Clear all
NCT06606912 2024-09-23

Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients

First Affiliated Hospital of Chongqing Medical University

Active not recruiting
4,000 enrolled
GastrointestinalOther

Gastrointestinal Neoplasms, Obesity, Stomach Neoplasms, Colorectal Neoplasms, Overweight, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡